Pulmonary edema; a complication of diabetic ketoacidosis.

PubWeight™: 0.93‹?›

🔗 View Article (PMID 6767583)

Published in Chest on May 01, 1980

Authors

C L Sprung, E C Rackow, I A Fein

Articles by these authors

Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med (1998) 13.94

Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med (1995) 10.29

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med (1991) 9.99

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA (1994) 5.24

A look into the nature and causes of human errors in the intensive care unit. Crit Care Med (1995) 5.14

Clinical antecedents to in-hospital cardiopulmonary arrest. Chest (1990) 4.94

The ACCP-SCCM consensus conference on sepsis and organ failure. Chest (1992) 4.35

Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med (2000) 3.00

End-tidal carbon dioxide concentration during cardiopulmonary resuscitation. N Engl J Med (1988) 2.80

Definitions for sepsis and organ failure. Crit Care Med (1992) 2.69

Prospectively defined indicators to improve the safety and quality of care for critically ill patients: a report from the Task Force on Safety and Quality of the European Society of Intensive Care Medicine (ESICM). Intensive Care Med (2012) 2.49

The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med (1984) 2.37

Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Crit Care Med (1983) 2.36

Endotracheal tube occlusion associated with the use of heat and moisture exchangers in the intensive care unit. Crit Care Med (1988) 2.34

Plasma cortisol levels in patients with septic shock. Crit Care Med (1990) 2.33

High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med (1987) 2.32

Evaluation of Institutional Review Board review and informed consent in publications of human research in critical care medicine. Crit Care Med (1998) 2.14

Recommendations for end-of-life care in the intensive care unit: The Ethics Committee of the Society of Critical Care Medicine. Crit Care Med (2001) 2.12

How to use an article on therapy or prevention: pneumonia prevention using subglottic secretion drainage. Crit Care Med (1997) 2.03

Decreases in mortality on a large urban medical service by facilitating access to critical care. An alternative to rationing. Arch Intern Med (1988) 1.86

Venous hypercarbia associated with severe sepsis and systemic hypoperfusion. Crit Care Med (1990) 1.74

Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels. J Infect Dis (1992) 1.73

Mechanical ventilation for the elderly patient in intensive care. Incremental changes and benefits. JAMA (1993) 1.72

Cardiac output and end-tidal carbon dioxide. Crit Care Med (1985) 1.71

Application of SOFA score to trauma patients. Sequential Organ Failure Assessment. Intensive Care Med (1999) 1.66

Difference in acid-base state between venous and arterial blood during cardiopulmonary resuscitation. N Engl J Med (1986) 1.66

Relationship of oxygen delivery and mixed venous oxygenation to lactic acidosis in patients with sepsis and acute myocardial infarction. Crit Care Med (1988) 1.58

The spectrum of septic encephalopathy. Definitions, etiologies, and mortalities. JAMA (1996) 1.53

Living related donation in lung transplantation. Ethical considerations. Arch Intern Med (1995) 1.53

Pulmonary artery catheterization. Can there be an integrated strategy for guideline development and research promotion? JAMA (1993) 1.51

Why have new effective therapies for sepsis not been developed? Crit Care Med (1994) 1.50

Expired carbon dioxide: a noninvasive monitor of cardiopulmonary resuscitation. Circulation (1988) 1.50

Effect of crystalloid and colloid solutions on blood rheology in sepsis. Shock (1997) 1.48

Alterations in C3, C4, factor B, and related metabolites in septic shock. Clin Immunol Immunopathol (1993) 1.44

Blast lung injury from an explosion on a civilian bus. Chest (1999) 1.42

HA-1A in septic patients with ARDS: results from the pivotal trial. Intensive Care Med (1994) 1.40

Unaccounted for anion in metabolic acidosis during severe sepsis in humans. Crit Care Med (1991) 1.40

Competent and continuing care of the critically ill. Crit Care Med (1988) 1.39

Acquired immunodeficiency syndrome and critical care. Crit Care Med (1990) 1.39

The first decade of the American Board of Internal Medicine certification in critical care medicine: an overview of examinees and certificate holders from 1987 through 1996. Crit Care Med (2000) 1.38

Monophosphoryl lipid A attenuates the effects of endotoxic shock in pigs. J Lab Clin Med (1992) 1.38

Definition of sepsis. Intensive Care Med (2001) 1.34

A look into the nature and causes of human errors in the intensive care unit. 1995. Qual Saf Health Care (2003) 1.31

Septic shock. Lancet (1998) 1.26

ICU survival of patients with the acquired immunodeficiency syndrome. Crit Care Med (1986) 1.24

Arteriovenous carbon dioxide and pH gradients during cardiac arrest. Circulation (1986) 1.24

Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock. Crit Care Med (2001) 1.19

Acute pulmonary edema in Plasmodium falciparum malaria. Am Rev Respir Dis (1978) 1.19

Decreased response to recall antigens is associated with depressed costimulatory receptor expression in septic critically ill patients. J Lab Clin Med (2000) 1.15

Optimum left heart filling pressure during fluid resuscitation of patients with hypovolemic and septic shock. Crit Care Med (1983) 1.14

Arterial PCO2 as an indicator of systemic perfusion during cardiopulmonary resuscitation. Crit Care Med (1989) 1.13

Comparison of blood lactate concentrations in central venous, pulmonary artery, and arterial blood. Crit Care Med (1987) 1.12

Altered leukocyte immunophenotypes in septic shock. Studies of HLA-DR, CD11b, CD14, and IL-2R expression. Chest (1993) 1.12

End-tidal CO2 as a guide to successful cardiopulmonary resuscitation: a preliminary report. Crit Care Med (1985) 1.11

Buffer agents do not reverse intramyocardial acidosis during cardiac resuscitation. Circulation (1990) 1.10

Triage considerations in medical intensive care. Arch Intern Med (1990) 1.07

Holy consent--a dilemma for medical staff when maternal consent is withheld for emergency caesarean section. Int J Obstet Anesth (2006) 1.07

Microvascular function and rheologic changes in hyperdynamic sepsis. Crit Care Med (1995) 1.06

Cardiopulmonary resuscitation in the rat. J Appl Physiol (1985) (1988) 1.06

Hemodynamic alterations of heat stroke in the elderly. Chest (1979) 1.03

Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: a prospective, double-blind, randomized, controlled trial. Crit Care Med (1995) 1.03

Evidence for increased permeability in reexpansion pulmonary edema. Am J Med (1981) 1.03

Is the physician's duty to the individual patient or to society? Crit Care Med (1995) 1.02

The impact of regional culture on intensive care end of life decision making: an Israeli perspective from the ETHICUS study. J Med Ethics (2006) 1.02

Effects of hetastarch and albumin on coagulation in patients with septic shock. J Clin Pharmacol (1988) 1.01

Ventricular arrhythmias during Swan-Ganz catheterization of the critically ill. Chest (1981) 1.01

Oxygen delivery and consumption in patients with hyperdynamic septic shock. Crit Care Med (1987) 1.00

Spontaneous intracerebral hemorrhage in critically ill patients: incidence over six years and associated factors. Intensive Care Med (1999) 0.99

The relationship of the colloid osmotic-pulmonary artery wedge pressure gradient to pulmonary edema and mortality in critically ill patients. Chest (1982) 0.99

Relationships between plasma cytokine concentrations and leukocyte functional antigen expression in patients with sepsis. Crit Care Med (1994) 0.98

Relation of colloid osmotic pressure to arterial hypoxemia and cerebral edema during crystalloid volume loading of patients with diabetic ketoacidosis. Ann Intern Med (1982) 0.98

Myocardial acidosis associated with CO2 production during cardiac arrest and resuscitation. Circulation (1989) 0.96

Foregoing life-sustaining treatment in an Israeli ICU. Intensive Care Med (1998) 0.96

The process of intensive care triage. Intensive Care Med (2001) 0.96

Hyperchloremic acidosis during the recovery phase of diabetic ketosis. Ann Intern Med (1978) 0.95

Effects of histamine on bronchial artery blood flow and bronchomotor tone. J Appl Physiol (1985) (1985) 0.95

Microvascular response in patients with cardiogenic shock. Crit Care Med (2000) 0.94

Prolongation of the half-life of lactate after maximal exercise in patients with hepatic dysfunction. Crit Care Med (1989) 0.94

The spectrum of pulmonary edema: differentiation of cardiogenic, intermediate, and noncardiogenic forms of pulmonary edema. Am Rev Respir Dis (1981) 0.94

'Lactate washout' following circulatory arrest. JAMA (1988) 0.94

Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Crit Care Med (1982) 0.93

Time course of organ failure in patients with septic shock treated with hydrocortisone: results of the Corticus study. Intensive Care Med (2011) 0.93

Neurogenic pulmonary edema. Chest (1982) 0.91

Early impairment of oxidative metabolism and energy production in severe sepsis. Circ Shock (1988) 0.91

Intramyocardial hypercarbic acidosis during cardiac arrest and resuscitation. Crit Care Med (1993) 0.91

Improved survival in patients with AIDS, Pneumocystis carinii pneumonia, and severe respiratory failure. Chest (1989) 0.90

Non-ICU care of hemodynamically stable mechanically ventilated patients. Chest (1996) 0.90

Complement activation and corticosteroid therapy in the development of the adult respiratory distress syndrome. Chest (1987) 0.90

Heat stroke; modern approach to an ancient disease. Chest (1980) 0.89

Monophosphoryl lipid A protects against gram-positive sepsis and tumor necrosis factor. Shock (1994) 0.89

Colloid osmotic pressure as a prognostic indicator of pulmonary edema and mortality in the critically ill. Chest (1977) 0.88

Traumatic macroglossia: a life-threatening complication. Crit Care Med (1999) 0.88